KABRA DRUG' LIMITED

KABRA
cIN-U)248MPr grgPr,Cfl )tt38

Date: 13th February, 2016

To,
The Corporate Relationship Department,
BSE Limited,
Phiroze feeieebhoy Towers, Dalal Street,
Mumbai - 400 001 (MH)

Reft Scrip Code 524322

Sub: OutcomeofBoard Meedng - Unaudlted Financlal Results for the Quarter and Nlne
Months ended 31"t December 2015.

Dear Slr/ Madam,

In Compliance of Regulation 30 of the SEBI (Listing ObligaHons and Disclosure

Requirements) Regulation, 20L5,we are pleased to enclose the Unaudited Financial Results
forthe Quarter and Nine Months Ended 31st December,2015 which have been duly approved
by the Board of Directors in its meeting held today i.e 13t February 2016. The Board
Meeting commenced at 03.00 p.m. and concluded at 4.00 p.m.

A copy of Limited Review Report on the standalone unaudited financial result is also
enclosed herewith.
+
Kindly take the same on your records.
Thankingyou,
Yours faithfully,
FO DRUGS LIMITED

Encl: as above

26, SECTOR" A" SANWER ROAD, INDUSTRTAL AREA INDORE M.P.

PHONE NO 073 l-27 21305, 27 227 56. & 27 22222
Email - kabradruss@redifftnai].com
 AgravJal lhavar Assodate
DHARMENDRA AGRAWAL 205 PanamaTower, Geeta Bhawan Square - 452001

Chanered Accountants Mobile :9826077125 Phone : 0731 2521508

Email id : dharmagca@yahoo.co.in

REVIEW REPORT FOR THE QUARTER ENDED 31ST DECEMBER, 2015

To,
The Board of Dlrectors
Kabra Drugs Limited

We have reviewed the accompanying statement of unaudited financial results of Kabra Drugs
Limited for the quarter ended 31* December, 2015. This statement is the responsibility of the
Company's Management and has been approved by the Board of Directors. Our responsibility is to
issue a report on these financial statements based on our review.

We conducted our review in accordance with the Standard on Review Engagement (SRE) 2400,
Engagements to Review Financial Statements issued by the Institute of Chartered Accountants of
lndia. This standard requires that we plan and perform the review to obtain moderate assurance as
to whether the financial statements are free of material misstatement. A review is limited primarily
to inquiries of company personnel and analytical procedures applied to financial data and thus
provide less assurance than an audit. We have not performed an audit and accordingly, we do not
express an audit opinion.

Based on our review conducted as above, nothing has come to our attention that causes us to
believe that the accompanying statement of unaudited financial results prepared in accordance
with applicable accounting standards and other recognized accounting practices and policies has
not disclosed the information required to be disclosed in terms ofRegulation 33 ofthe SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015 including the manner in which it is to
be disclosed, or that it contains any material misstatement.

For Agrawal Jhawar & Associates

Chartered Accountants
(Firm Reg. No. 008614C)

g/%.^a
Dhamendra Agrawal
Partner
M.No.77507 I
I

Place: Indore
Dated: 13th Febrt ary, 2O16
 KABRA DRUGS LINIITED
CI\: L02423MPl989Pt C005.1,.r
Regd. r. i;aDwer Ro6,i.Indushal Estate, lndore-45:'00l(M P )
OfIc 26.r--ir.
KABRA
hor)Ii-r!ril\ Dr.il l(abrdc,.Lcl@red'rmgIgI_.

sEtehent of statrd.lor. unaudlred iBulrs for rlt. a.d 9 mo.rh. End.d 31.12.2015

I{grq! B.lolY)
31.12.1015 30.(x)2015 3l,l2.2Ol,t 31.r2..201s ?1.122011 Ir.032015
I lr.otu. fom op.ntioc
'aJll.rsales lin.bh. fmm ophdon 230.12 661.27 620.60
{.jr)th(rontrr rlein.one 029 053 029 0.13
'rnr,l in.o . 160 op.ErioB (ner) 223.19 196.15 23r.0, 426.90

I , a!* or i.rLi i ,rl! .Jnsuncd r37.45 500.20 543 3l

rh, P!&haseotsto(k in TBde
l (r J Chanpc I irr /en(ries oi nnishd roods. W.ri .in'Dron.Ers ahd io.r
2.i4 615
(u) Emplor"e b"ne-'i rxpense 74 5? t4.32 42.2',7 36.25
arr l).pr..iatr,ni.dif'.ftrsationerpense 5.76 1485 23.O1
24.t3 33 29 36.19 3635
219.02 193.30 225,SS 651.91 602,56 416.29
s) ftof, opcEtionr tJ18 0
' ' lrnd
,nd E; tcptioDl I1lbs (1.2) 4A7 2.77 4,16 12.69 1&33 10.61
4l( 0.00 0.00 0.00 0.00
5
&@otonai items (3+4) 2.71 5,16 72.49 1433 ,0.61
0.00 000
.D.r! but t aon'
eft.rrional lrems(s+6) 2.77 t2flt 1&33
-@n..
5?a( 12.a!) 1&33
t 0.00 o.t o 0.oo 0.fi, 0.00 3.55
l1 t.r aonr/(I6) ,ior Hi@ry .t drtriB .h.. r[ 2.71 5.,46 l2t9 -:t3
tz F* raDrdndry h.ms( nd or d .xp.hs. ) 0.oo
l3 i"{ Protu /tl6s)ror the period(111 2) 12tl' ,f,t3
I 0.0c
l5 M 0.00

2.77 at6 12.89 1Ai3

t7 P.ld ur.qtrny rhare apilrl ,!3436 434.45 43a.a5 43l.45
lt c. vrluco,R..10 cachl
J0l R.s.r.s q.hdi.g R.v.ltratio! Res6 .s tfr B.lan.e 3ter of
r..oui'i4 year
0 0 0 -r7&37
lpcvroG
.19
i. .isming p. r sh.rc (b.roE kEodiEry h.o!,
.tn! r0 -,.h) [] otannu,lisedl
01 0.06 0.12 o.29 o12
01 0.12 0.29 o.12
li, E.iri ns n.r .h.e (air. dt@di.a., ios)
!-::.!ret-re!lEel- -
o.12 o29
- 0.12 o.29 0.42

l
Tte above results dulyrev..wed byAudit Co rmiLtle, hav been approved by the Board ofDlrectors in rts mehng held o.13rh February20l6
2 prvious ye.r figures bavebcn regrouped/.earran[.d whe.ever necessary.
i StaturoI, ru.ttors ofthe corrpanyhave (arrieo outa rirnited reviewo[above rcsulL

Date .13,02.1-116 h,f

Ixrcctof,
Ctdstl &
Dir:0076C420